Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

120mg Fexofree Fexofenadine Hydrochloride Tablets

₹ 105/Box

Strength120 mg
Packaging Size100 Tablets
Packaging TypeBox
BrandFexofree
CompositionFexofenadine Hcl
TreatmentUsed for treating seasonal allergic conditions such as hay fever.
AvailabilityIn Stock
Tablet is used for treating seasonal allergic conditions such as hay fever. It helps to relieve allergies of the nose (allergic rhinitis), sneezing, runny nose, itching in the eyes, excessively watery eyes, etc.

Exports To: Bangladesh | United States Of America | Nepal | Australia | United Kingdom

Find products similar to 120mg Fexofree Fexofenadine Hydrochloride Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
02-07-2019
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
25 - 100 Cr
IndiaMART Member Since
July 2014
GST
04AAECJ5472E1ZR
Import Export Code (IEC)
AAECJ*****
Exports to
Bangladesh | United States Of America | Nepal | Australia | United Kingdom

Established in the year of 2019, We “Janus Biotech India Private Limited” are Wholesaler,Distributor And Exporter of an Pharmaceutical Tablets, Pharmaceutical Tablets And Capsule, PCD Pharma Franchise, Pharmaceutical Syrup, Medicine Products, Pharmaceutical Capsules, Ayurvedic Syrup and Tablets and Capsules, Pharmaceutical Injection. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Harsimran Singh, whose continual backing and direction have been useful to us for attaining exponential development in the current market.